Parkinson's disease: clinical features and diagnosis
J Jankovic - Journal of neurology, neurosurgery & psychiatry, 2008 - jnnp.bmj.com
Objective: Parkinson's disease (PD) is a progressive neurological disorder characterised by
a large number of motor and non-motor features that can impact on function to a variable …
a large number of motor and non-motor features that can impact on function to a variable …
Parkinson's disease
AE Lang, AM Lozano - New England Journal of Medicine, 1998 - Mass Medical Soc
Pathophysiology The establishment of a model of parkinsonism through the administration
of MPTP to nonhuman primates has provided important insights into new therapeutic …
of MPTP to nonhuman primates has provided important insights into new therapeutic …
The diagnosis of Parkinson's disease
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for …
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for …
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
OBJECTIVE: Since all antipsychotics block dopamine D2 receptors, the authors investigated
how well D2 receptor occupancy in vivo predicts clinical response, extrapyramidal side …
how well D2 receptor occupancy in vivo predicts clinical response, extrapyramidal side …
[HTML][HTML] PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases
Molecular imaging is an attractive technology widely used in clinical practice that greatly
enhances our understanding of the pathophysiology and treatment in central nervous …
enhances our understanding of the pathophysiology and treatment in central nervous …
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
A Iranzo, F Valldeoriola, F Lomeña… - The Lancet …, 2011 - thelancet.com
Background Serial dopamine transporter (DAT) imaging in patients with Parkinson's disease
(PD) and other synucleinopathies shows progressive nigrostriatal dopaminergic dysfunction …
(PD) and other synucleinopathies shows progressive nigrostriatal dopaminergic dysfunction …
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression
Parkinson Study Group, Parkinson Study Group - Jama, 2002 - jamanetwork.com
ContextPramipexole and levodopa are effective medications to treat motor symptoms of
early Parkinson disease (PD). In vitro and animal studies suggest that pramipexole may …
early Parkinson disease (PD). In vitro and animal studies suggest that pramipexole may …
Looking backward to move forward: early detection of neurodegenerative disorders
ST DeKosky, K Marek - Science, 2003 - science.org
Early detection of neurodegenerative disorders would provide clues to the underlying
pathobiology of these diseases and would enable more effective diagnosis and treatment of …
pathobiology of these diseases and would enable more effective diagnosis and treatment of …
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
J Darcourt, J Booij, K Tatsch, A Varrone… - European journal of …, 2010 - Springer
These guidelines summarize the current views of the European Association of Nuclear
Medicine Neuroimaging Committee (ENC). The aim of the guidelines is to assist nuclear …
Medicine Neuroimaging Committee (ENC). The aim of the guidelines is to assist nuclear …
[123I] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
J Booij, G Tissingh, GJ Boer, JD Speelman… - Journal of Neurology …, 1997 - jnnp.bmj.com
OBJECTIVES: The main neuropathological feature in Parkinson's disease is a severe
degeneration of the dopaminergic neurons in the substantia nigra resulting in a loss of …
degeneration of the dopaminergic neurons in the substantia nigra resulting in a loss of …